Short communication · 3 May 2025
Review articlePublished 2018
Ovarian Cancer - The Silent Killer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Ovarian cancer is heterogeneous, multigenetic and epigenetic abnormalities and lethal among all other gynecological women malignancies amongst women. Moreover, ovarian cancer has a distinct biology and behavior at cellular and molecular level. According to National Cancer Institute’s Surveillance, Epidemiology and End Result Program Report in 2017 the new case of ovarian cancer exacerbated to 22.4% from 11.7% in 2014. The Therapeutics use of cancer therapies has been restricted due to its nonspecific and dose limiting cellular toxicity and development of multidrug resistance. To overcome the restriction various biotechnological therapies and drug delivery system have been described in this review.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Tumor Research.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Tumor Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Debashis Dutta”
